Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Neurosurgical Focus|June 2, 2005
Reconstruction of the superior sagittal sinus with silicone tubingJingjian Ma, Tianqiang Song, Wang Hu, et al.
Journal of Hepatocellular Carcinoma|January 17, 2024
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical TherapyRuyu Han, Leijuan Gan, Mengran Lang, et al.
Biomaterials Science|January 23, 2020
Optimized fluorodendrimer-incorporated hybrid lipid-polymer nanoparticles for efficient siRNA deliveryQingqing Xiong, Yujing Li, Kun Zhou, et al.
Nutrition and Cancer|September 3, 2020
Perioperative Enteral Nutrition Improves Postoperative Recovery for Patients with Primary Liver Cancer: A Randomized Controlled Clinical TrialXiaopeng Yan, Lianxin Liu, Yamin Zhang, et al.
Cancer Research|January 17, 2015
Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathwayMing Cui, Zelin Xiao, Yue Wang, et al.
Frontiers in Genetics|January 26, 2023
The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinomaLiwei Chen, Yuchao He, Zhiqiang Han, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 6, 2010
Treatment of colorectal cancer with unresectable synchronous liver-only metastases with combined therapeutic modalitiesYunlong Cui, Huikai Li, Qiang Wu, et al.
Journal of Hepatocellular Carcinoma|October 3, 2024
Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched StudyRuyu Han, Leijuan Gan, Liyu Sun, et al.
Bioscience Trends|March 26, 2013
Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in ChinaPeipei Song, Xiaobin Feng, Keming Zhang, et al.
Journal of Cancer Research and Clinical Oncology|July 8, 2022
Triple therapy in biliary tract cancers: GemOX plus immune checkpoint inhibitor in combination with lenvatinib or NGS-guided targeted therapyXiang Dong, Zewu Zhang, Qin Zhang, et al.
Pageof 12